desogestrel has been researched along with Menopause in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (9.09) | 18.7374 |
1990's | 7 (63.64) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Godsland, IF; Wynn, V | 1 |
Crook, D; Ellerington, M; Lees, B; Marsh, MS; Stevenson, JC; Whitcroft, S; Whitehead, MI; Worthington, M | 1 |
Creinin, MD | 1 |
Christensen, A; Damber, MG; Hirvonen, E; Milsom, I; Saure, A | 1 |
Amram, A; Battaglia, C; Cagnacci, A; Volpe, A | 1 |
Jaszczak, P; Planellas, J; Poulsen, HK; Saure, A | 1 |
Gloudemans, RH; Groothuis, GM; Peeters, PA; Rietjens, IM; van Lier, JJ; Verheggen, FT; Verhoeven, CH; Vos, RM | 1 |
Diamant, YZ; Goldstein, R; Kleinman, Y; Tadmor, OP | 1 |
Anderson, DC; Buckler, HM; Burger, HG; Evans, CA; Mamtora, H | 1 |
Christiansen, C; Haarbo, J; Hassager, C; Jensen, SB; Riis, BJ | 1 |
4 trial(s) available for desogestrel and Menopause
Article | Year |
---|---|
A randomized, double-blind, multicentre study comparing the clinical effects of two sequential estradiol-progestin combinations containing either desogestrel or norethisterone acetate in climacteric women with estrogen deficiency symptoms.
Topics: Administration, Oral; Climacteric; Desogestrel; Double-Blind Method; Endometrial Hyperplasia; Endometrium; Estradiol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Patient Compliance; Physical Fitness; Placebos; Postmenopause; Progesterone Congeners; Sweating; Uterine Hemorrhage | 1996 |
Biochemical aspects of hormonal contraception: effects on bone metabolism.
Topics: Alkaline Phosphatase; Bone Density; Bone Remodeling; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Creatinine; Desogestrel; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydroxyproline; Menopause; Middle Aged; Osteocalcin; Progesterone Congeners | 1997 |
A double-blind, randomized, comparative study evaluating clinical effects of two sequential estradiol-progestogen combinations containing either desogestrel or medroxyprogesterone acetate in climacteric women.
Topics: Administration, Oral; Blood Pressure; Climacteric; Desogestrel; Double-Blind Method; Estradiol; Estrogens, Conjugated (USP); Female; Flushing; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Mood Disorders; Placebos; Progesterone Congeners; Sweating; Uterine Hemorrhage | 2000 |
Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
Topics: Androgen Antagonists; Apolipoproteins; Cyproterone; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipid Metabolism; Lipids; Lipoproteins; Medroxyprogesterone; Menopause; Middle Aged; Norgestrel; Norpregnenes | 1991 |
7 other study(ies) available for desogestrel and Menopause
Article | Year |
---|---|
ACOG Practice Bulletin No. 121: Long-acting reversible contraception: Implants and intrauterine devices.
Topics: Abortion, Induced; Abortion, Spontaneous; Actinomyces; Antibiotic Prophylaxis; Bone Density; Breast Feeding; Cervix Uteri; Contraceptive Agents, Female; Copper; Desogestrel; Device Removal; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Menstrual Cycle; Postpartum Period; Pregnancy; Pregnancy Outcome; Pregnancy, Ectopic; Sexually Transmitted Diseases | 2011 |
Progestagens and high-density lipoproteins.
Topics: Desogestrel; Female; Humans; Lipoproteins, HDL; Menopause; Norpregnenes | 1984 |
The effects of oral desogestrel and estradiol continuous combined hormone replacement therapy on serum lipids and body composition in postmenopausal women.
Topics: Absorptiometry, Photon; Adipose Tissue; Body Composition; Desogestrel; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Lipoproteins; Menopause; Middle Aged | 1993 |
Laboratory criteria for menopause in women using oral contraceptives.
Topics: Adult; Aged; Contraceptives, Oral; Desogestrel; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Menopause; Middle Aged; Norgestrel; Pilot Projects; Prospective Studies; Time Factors | 1996 |
Excretion and metabolism of desogestrel in healthy postmenopausal women.
Topics: Administration, Oral; Animals; Biotransformation; Chromatography, High Pressure Liquid; Desogestrel; Dogs; Estrogen Replacement Therapy; Feces; Female; Glucuronides; Humans; Hydroxylation; In Vitro Techniques; Intestinal Mucosa; Liver; Menopause; Molecular Structure; Progesterone Congeners; Rats; Species Specificity | 2001 |
The effect of desogestrel for hormone replacement therapy on the blood lipid profiles of postmenopausal women.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Desogestrel; Drug Combinations; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estriol; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norethindrone; Prospective Studies; Time Factors; Triglycerides | 1992 |
Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles.
Topics: Adult; Anovulation; Desogestrel; Estradiol; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Follicle Stimulating Hormone; Humans; Infertility, Female; Inhibins; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Norgestrel; Norpregnenes; Ovarian Diseases; Ovulation; Progesterone; Progestins | 1991 |